Notice NOT-CA-24-094 from the NIH Guide for Grants and Contracts

Notice NOT-CA-24-090 from the NIH Guide for Grants and Contracts

Notice NOT-LM-24-003 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-25-026 from the NIH Guide for Grants and Contracts. The goal of this Notice of Funding Opportunity (NOFO) is to support research to investigate mitochondrial-nuclear communication in the context of neurobiology and Alzheimer's disease and AD-related dementias (AD/ADRD). This research will transform our understanding of how mitochondrially derived metabolites can impact nuclear gene expression and how changes to nuclear function can impact mitochondrial activity. This has the potential to serve as the foundation for the development of future AD/ADRD therapies that specifically target mitochondrial function as well as shed light on the role that mitochondria play in aging and neurodegeneration.

Funding Opportunity RFA-CA-24-025 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to provide the infrastructure for early-phase cancer prevention clinical trials through the Cancer Prevention Clinical Trials Network (CP-CTNet), DCP's main mechanism for early clinical development of cancer preventive interventions. The phase 0-2 trials performed through CP-CTNet evaluate biologic effects of interventions and determine clinically relevant correlates, with the ultimate goal of advancing their further development for cancer prevention. The research network will develop multiple cancer prevention clinical trials targeting cancers arising in various organ sites, including collaborative studies across the Network, using the UG1 cooperative agreement funding mechanisms. This NOFO relates to the data management, auditing and statistical center that provides database support, auditing functions, statistical support, and coordinating functions for the network.

Funding Opportunity RFA-CA-24-024 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to provide the infrastructure for early-phase cancer prevention clinical trials through the Cancer Prevention Clinical Trials Network (CP-CTNet), DCP's main mechanism for early clinical development of cancer preventive interventions. The phase 0-2 trials performed through CP-CTNet evaluate biologic effects of interventions and determine clinically relevant correlates, with the ultimate goal of advancing their further development for cancer prevention. The research network will develop multiple cancer prevention clinical trials targeting cancers arising in various organ sites, including collaborative studies across the Network, using the UG1 cooperative agreement funding mechanisms. This NOFO relates to the performance sites that will plan and perform clinical trials.

Funding Opportunity PAR-24-260 from the NIH Guide for Grants and Contracts. The purpose of the Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) award is to support federally recognized American Indian/Alaska Native (AI/AN) Tribes, Tribal colleges and universities, Tribal health programs, or Tribal organizations(collectively, eligible Tribal entities) to establish Institutional Review Boards (IRBs) or enhance the capacity of existing Tribal IRBs.

CEDARS-SINAI: Join Dr. Simon Knott and his research group as a Research Associate II! The goal of the Knott Laboratory is to develop cancer treatment strategies... Beverly Hills, California

CEDARS-SINAI: Join Dr. Simon Knott and his research group as a Research Associate II! The goal of the Knott Laboratory is to develop cancer treatment strategies... Beverly Hills, California

CEDARS-SINAI: When the work you do every single day has a crucial impact on the lives of others, every effort, every detail, and every second matters. This shar... Los Angeles, California

CEDARS-SINAI: When the work you do every single day has a crucial impact on the lives of others, every effort, every detail, and every second matters. This shar... Los Angeles, California

CEDARS-SINAI: When the work you do every single day has a crucial impact on the lives of others, every effort, every detail, and every second matters. This shar... Los Angeles, California

CEDARS-SINAI: When the work you do every single day has a crucial impact on the lives of others, every effort, every detail, and every second matters. This shar... Los Angeles, California

Rowan University: Job no: 499528 Work type: Regular Full-Time Location: Glassboro, New Jersey Categories: Faculty - College of Science and Mathematics Open Rank Tenu... Glassboro, New Jersey

Santen, Inc.: Company Description Santen is a specialized pharmaceutical company with a 130-year heritage focused exclusively on ophthalmology. With sales in ove... Emeryville, California

Acrivon Therapeutics: Acrivon is a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicte... Watertown, Massachusetts

Mammoth Biosciences: OPPORTUNITY Mammoth's Editing Technologies team is hiring a Sr. Scientist I/II to play a lead role in the development of a next-generation genome e... Brisbane, California

The University of Texas at Arlington: Posting Number: F00546P Position Title: Multiple Open Rank Faculty Positions - Precision Health and Informatics Cluster Department: Provost Office... Arlington, Texas

Grossmont-Cuyamaca Community College District: Biology Faculty (Cellular, Molecular, And Evolutionary Biology) - Tenure Track R-01765 San Diego County - Grossmont College Transforming lives thro... El Cajon, California

Notice NOT-RM-24-012 from the NIH Guide for Grants and Contracts